RIBAZOLE

This brand name is authorized in Nigeria.

Active ingredients

The drug RIBAZOLE contains one active pharmaceutical ingredient (API):

1	Ribavirin UNII 49717AWG6K - RIBAVIRIN
	Ribavirin is a synthetic nucleoside analogue which has shown in vitro activity against some RNA and DNA viruses. The mechanism by which ribavirin in combination with other medicinal products exerts its effects against HCV is unknown.
	Read more about Ribavirin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-3864	Capsule	Ribazole 400 mg Capsules CAP 400 mg	Ribazole 400 mg Capsules B4-3864 Ribavirin Antiviral Oral 400 mg Capsule Prescription Only Medicine (Pom) Getz Pharm Ltd Getz Pharma (Private) Limited Pakistan 30/11/2020 29/11/2025	30/11/2020

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J05AP01		J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AP Antivirals for treatment of HCV infections
Discover more medicines within J05AP01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-3864